Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

939.7500 -4.70 (-0.50%)

NSE Aug 08, 2025 12:37 PM

29.04% Fall from 52W High

Volume: 250.1K

Zydus Lifesciences Ltd.

02 Jun 2025

939.75

-0.50%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives tentative approval from the USFDA for Rifaximin Tablets 550 mg

More from Zydus Lifesciences Ltd.

Recommended

Market trades lower, Ramco Cements' Q1FY26 net profit misses Forecaster estimates by 7.1%

Trendlyne Marketwatch | 08 Aug 2025, 12:31PM

Chart of the Week: Mutual funds and FIIs bet big on 11 Nifty 500 stocks in Q1FY26

The Baseline | 07 Aug 2025, 05:53PM

Earnings Call Transcript - Cadila Healthcare